BNS:TSX
Bank of Nova Scotia
Data as of 2026-03-10 - not real-time
CA$96.23
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The Bank of Nova Scotia is trading at CA$96.23, comfortably above the calculated support of CA$94.84 but below its 20‑day (CA$102.96) and 50‑day (CA$102.34) moving averages, signaling short‑term pressure. The RSI of 29.9 places the stock in oversold territory, while the MACD remains bearish, suggesting a potential bounce off support before any upward move. On a longer horizon the price sits above the 200‑day SMA (CA$89.34) and the beta of 0.36 indicates low market‑wide volatility, reinforced by a 30‑day volatility of roughly 18%. Valuation metrics are attractive – a trailing PE of 14.5 versus an industry average of 17.4 and a forward PE of 10.5, combined with a projected upside of about 12% and a dividend yield near 4.5%.
Strategically, Scotiabank’s recent partnership in the Defence, Security and Resilience Bank opens a niche financing channel that could enhance earnings beyond its solid 23.5% revenue growth and 37% operating margin. The balance sheet is heavily cash‑rich (CAD$493 bn) relative to debt (CAD$316 bn), supporting a payout ratio of 64.7% and making the dividend appear sustainable. While operating cash flow is currently negative, the overall risk profile is modest – low systematic risk, moderate sector and regulatory exposure, and ample liquidity – positioning BNS as a compelling value‑oriented, dividend‑focused play.
Strategically, Scotiabank’s recent partnership in the Defence, Security and Resilience Bank opens a niche financing channel that could enhance earnings beyond its solid 23.5% revenue growth and 37% operating margin. The balance sheet is heavily cash‑rich (CAD$493 bn) relative to debt (CAD$316 bn), supporting a payout ratio of 64.7% and making the dividend appear sustainable. While operating cash flow is currently negative, the overall risk profile is modest – low systematic risk, moderate sector and regulatory exposure, and ample liquidity – positioning BNS as a compelling value‑oriented, dividend‑focused play.
Trading Recommendations
Short Term
< 1 yearbuy
Conviction: 7/10
Key Factors
- Oversold RSI indicating near‑term price floor
- Support level at CA$94.84 with increasing volume
- Attractive dividend yield above 4%
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- Undervalued PE relative to peers
- Strong revenue growth and operating margins
- Strategic partnership expanding fee‑based income
Long Term
> 3 yearshold
Conviction: 6/10
Key Factors
- Sustainable dividend backed by robust cash position
- Low beta and modest volatility reducing market risk
- Potential macro‑economic headwinds affecting banking sector
Key Metrics & Analysis
Financial Health
Revenue Growth23.50%
Profit Margin26.85%
P/E Ratio14.5
ROE10.33%
ROA0.62%
P/B Ratio1.4
Op. Cash FlowCA$-30787000320
Industry P/E17.4
Technical Analysis
TrendBullish
RSI29.9
SupportCA$94.84
ResistanceCA$106.39
MA 20CA$102.96
MA 50CA$102.34
MA 200CA$89.34
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Target PriceCA$108.00
Upside/Downside12.23%
GradeUndervalued
TypeBlend
Dividend Yield4.49%
Risk Assessment
Beta0.37
Volatility18.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.